AstraZeneca Re-Releases COVID Jab Trial Data After Rebuke From US Regulator
March 25, 2021 at 10:22 AM EDT
Earlier this week, AstraZeneca managed to destroy the last remaining shreds of its credibility by prematurely releasing an analysis of its COVID vaccine Phase 3 trial data.
